Countries citing papers authored by Jingoro Shimada
Since
Specialization
Citations
This map shows the geographic impact of Jingoro Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingoro Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingoro Shimada more than expected).
This network shows the impact of papers produced by Jingoro Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingoro Shimada. The network helps show where Jingoro Shimada may publish in the future.
Co-authorship network of co-authors of Jingoro Shimada
This figure shows the co-authorship network connecting the top 25 collaborators of Jingoro Shimada.
A scholar is included among the top collaborators of Jingoro Shimada based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Jingoro Shimada. Jingoro Shimada is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Kamidono, Sadao, Soichi Arakawa, Takaoki Hirose, et al.. (2005). Double-blind, controlled study to evaluate safety and efficacy of doripenem and meropenem in patients with complicated urinary tract infection. 53. 244–259.3 indexed citations
4.
Saitô, Atsushi, Akira Watanabe, Nobuki Aoki, et al.. (2005). A dose-finding study on doripenem in chronic respiratory tract infection. 53. 169–184.1 indexed citations
5.
Saitô, Atsushi, Akira Watanabe, Koichiro Nakata, et al.. (2005). Comparative study of doripenem and meropenem in respiratory infections. Phase III double-blind comparative study. 53. 185–204.3 indexed citations
6.
Saito, Atsushi, et al.. (2005). A study of doripenem efficacy and safety in internal medicine. Chemotherapy. 53(1). 157–168.1 indexed citations
7.
Inoué, Yoshihiro, Akiko Shiraishi, Toshiko Hada, Hajime Hamashima, & Jingoro Shimada. (2004). The Antibacterial Effects of Myrcene on Staphylococcus aureus and Its Role in the Essential Oil of the Tea Tree (Melaleuca alternifolia). Natural medicines = 生薬學雜誌. 58(1). 10–14.21 indexed citations
8.
Hada, Toshiko, Akiko Shiraishi, Yoshihiro Inoué, et al.. (2003). Inhibitory effects of terpenes on the growth of Staphylococcus aureus. Natural medicines = 生薬學雜誌. 57(2). 64–67.24 indexed citations
Yoshida, Masaki, Jingoro Shimada, Atsushi Saitô, et al.. (1993). Clinical studies of loracarbef. Chemotherapy. 41. 184–187.3 indexed citations
17.
Saito, Atsushi, Jingoro Shimada, Seiji Hori, et al.. (1990). Effect of antacid on gastrointestinal absorption of fleroxacin in healthy humans. Chemotherapy. 38. 344–346.2 indexed citations
18.
Hori, Seiji, et al.. (1988). Effect of T-3262 and its structural derivatives on GABA receptor binding. Chemotherapy. 36(9). 116–120.5 indexed citations
19.
Saitô, Atsushi, et al.. (1984). Clinical studies on ceftriaxone (Ro 13-9904). Chemotherapy. 32. 259–278.2 indexed citations
20.
Matsumoto, Fumio, et al.. (1980). CLINICAL STUDIES OF CEFOTAXIME. 28(1). 218–227.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.